Table 1.
Parameter | CSU patients with normal D-dimer (=<250 ng/mL) (Total n=95) | CSU patients with raised D-dimer (>250 ng/mL) (Total n=46) | P |
---|---|---|---|
Age (years; mean±SD) | 34.45±11.87 | 36.17±11.17 | 0.41 |
Sex (F/M) | 59/36 | 29/17 | 0.91 |
Duration (months) | 45.6±23.8 | 44.9±22.5 | 0.85 |
Presence of angioedema | 40 (42.1%) | 25 (54.3%) | 0.17 |
History of Atopy | 31 (32.6%) | 13 (28.3%) | 0.59 |
Presence of thyroid abnormality | 10 (10.5%) | 5 (12.2%) | 1.00 |
Family history of urticaria | 12 (12.6%) | 5 (12.2%) | 0.76 |
Positive ASST | 37 (38.9%) | 18 (39.1%) | 0.98 |
Positive APST | 24 (25.3%) | 13 (28.3%) | 0.70 |
Mean Serum Ig E (kU/L) (Mean±SD) | 440.6±569.12 | 756.5±1724.41 | 0.10 |
Serum Ig E raised (>100 kU/L) | 70 (73.7%) | 35 (76.1%) | 0.75 |
Mean UAS 0 weeks (Mean±SD) | 12.46±4.87 | 16.45±5.12 | <0.001* |
Number of patients having mild, moderate and severe grading of baseline UAS7 | |||
Mild | 27 | 4 | <0.001 |
Moderate | 48 | 18 | * |
Severe | 20 | 24 | |
PT (in seconds) (Mean±SD) | 11.06±1.34 | 11.88±1.55 | 0.002* |
PT raised | 7 (7.4%) | 17 (36.9%) | <0.001* |
APTT (in seconds) (Mean±SD) | 33.33±3.26 | 36.48±4.32 | <0.001* |
APTT raised | 4 (4.2%) | 18 (39.1%) | <0.001* |
Dose of antihistamine required | |||
Single | 19 | 2 | <0.001 |
Two-fold | 21 | 1 | * |
Three-fold | 20 | 5 | |
Four-fold | 35 | 38 | |
Second-line drugs used | 22 (23.1%) | 34 (73.9%) | <0.001 |
Azathioprine | 12 (12.6%) | 19 (41.3%) | * |
Cyclosporine | 10 (10.5%) | 15 (32.6%) |
*Significant P values; +- SD- Standard Deviation